Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam

Bibliographic Data

ID15540657
AuthorsHazel V J Moir (0000-0003-1398-6748, Australian National University, corresponding author), Brigitte Tenni (0000-0002-3356-4967, The University of Melbourne), Deborah Gleeson (0000-0001-8021-9130, La Trobe University), Ruth Lopert (0000-0002-0882-4288, George Washington University)
Year2016
Volume13
Issue4
Pages400-413
Publication date2016-11-14
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueGlobal Public Health (JOURNAL)
Journal identifiersISSN: 1744-1692 • E-ISSN: 1744-1706
PublisherTaylor & Francis (PUBLISHER • GB)
DOI10.1080/17441692.2016.1256418
PMID27841097
OpenAlexW2551884878
LanguageEN
Citations received4
References cited11

In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA successfully pursued intellectual property (IP) provisions that will affect the affordability of medicines, including anti-retrovirals (ARV) for HIV. Vietnam has the lowest GDP per capita of the 12 TPP countries and in 2013 provided ARVs for only 68% of eligible people living with HIV. Using the current Vietnamese IP regime as our base case, we analysed the potential impact of a regime making full use of legal IP flexibilities, and one based on the IP provisions of the final, agreed TPP text. Results indicate that at current funding levels 82% of Vietnam's eligible people living with HIV would receive ARVs if legal flexibilities were fully utilised, while as few as 30% may have access to ARVs under the TPP Agreement - more than halving the proportion currently treated

Business · Economic growth · Economic partnership agreement · Economics · Environmental health · Family medicine · General partnership · Human immunodeficiency virus (HIV · Intellectual property · International trade · Negotiation · Per capita · Political science · Population · Socioeconomics · Vietnamese · Intellectual Property and Patents · International Development and Aid · Law · Medicine · Pharmaceutical Economics and Policy

  • Defending access to medicines in regional trade agreements

    Open Access•Billie Townsend•Globalization and Health•2021

  • What is the impact of intellectual property rules on access to medicines? A systematic review

    Open Access•Brigitte Tenni, Hazel V J Moir et al.•Globalization and Health•2022

  • The Trans Pacific Partnership Agreement, intellectual property and medicines

    Open Access•Deborah Gleeson, Joel Lexchin et al.•Global Social Policy•2017

  • Patents, trade and medicines

    Kenneth C Shadlen, Bhaven Sampat et al.•Review of International Political…•2019

  • Ceta and pharmaceuticals

    Open Access•Joel Lexchin, Marc-André Gagnon•Globalization and Health•2014

  • Evolving trade policy and the Trans-Pacific Partnership Agreement

    Open Access•Linh Nguyen, Huong Thanh Nguyen et al.•Global Public Health•2014

  • Changing Drug Markets Under New Intellectual Property Regimes

    Angelina Snodgrass Godoy, Alejandro Cerón•American Journal of Public Health•2011

Unique citing works4
Citations per year0.44
Citation span2017 - 2022 (6)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 4

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae